Remodeling beim Asthma

Lernziel

In diesem Artikel wird beschrieben, was unter Remodeling verstanden wird und was dies für den Asthmapatienten bedeutet. Es wird veranschaulicht, welche Zellstrukturen dabei betroffen sind, ob diese Veränderungen irreversibel oder reversibel sind und inwieweit die aktuell auf dem Markt befindlichen Medikamente oder evtl. zukünftig zur Verfügung stehende Pharmaka diesen Prozess für den Patienten spürbar beeinflussen können.

• Literatur

• 1 Elias JA, Zhu Z, Chupp G et al. Airway remodeling in asthma. Proc Am Thorac Soc 2009; 6: 301-305
• 2 Girodet PO, Ozier A, Bara I et al. Airway remodeling in asthma: new mechanisms and potential for pharmacological intervention. Pharmacol Ther 2011; 130: 325-337
• 3 Jeffery PK. Structural and inflammatory changes in COPD: a comparison with asthma. Thorax 1998; 53: 129-136
• 4 Jeffery PK. Remodelling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004; 1: 176-183
• 5 Laitinen LA, Laitinen A, Haahtela T. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol 1992; 90: 32-42
• 6 Ordonez C, Ferrando R, Hyde DM et al. Epithelial desquamation in asthma: artifact or pathology ?. Am J Respir Crit Care Med 2010; 162: 2324-2329
• 7 Holgate ST, Roberts G, Arshad HS et al. The role of the airway epithelium and its interaction with environmental factors in asthma pathogenesis. Proc Am Thorac Soc 2009; 6: 655-659
• 8 Takeyama K, Fahy JV, Nadel JA. Relationship of epidermal growth factors to goblet cell production in human bronchi. Am J Respir Crit Care Med 2001; 163: 511-516
• 9 Shim JJ, Dabbagh K, Ueki IF et al. IL-13 induced mucin production by stimulation epidermal growth factor receptors and by activating neutrophils. AmJ Physiol Lung Cell Mol Physiol 2001; 280: L134-L140
• 10 Holgate ST. The airway epithelium is central to the pathogenesis of asthma. Allergol Int 2008; 57: 1-10
• 11 Payne DN, Rogers AV, Adelroth E et al. Early thickening of the reticular basement membrane in children with difficult asthma. Am J Respir Crit Care Med 2003; 167: 78-82
• 12 Bergeron C, Tulic MK, Hamid Q. Airway remodelling in asthma: from benchside to clinicial practice. Can Respir J 2010; 17: e85-e94
• 13 Yick CY, von der Thüsen JH, Bel EH et al. In vivo imaging of the airway wall in asthma: fibered confocal fluorescence microscopy in relation to histology and lung function. Respir Res 2011; 12: 85-
• 14 Milanese M, Crimi E, Scordamaglia A et al. On the functional consequences of bronchial basement membrane thickening. J Appl Physiol 2001; 91: 1035-1040
• 15 Palmans E, Kips JC, Pauwels RA. Prolonged allergen exposure induces structural airway changes in sensitized rats. Am.J.Respir.Crit.Care Med 2000; 161: 627-635
• 16 Westergren-Thorsson G, Chakir J, Lafreniere-Allard MJ et al. Correlation between airway responsiveness and proteoglycan production by bronchial fibroblasts from normal and asthmatic subjects. Int J Biochem Cell Biol 2002; 34: 1256-1267
• 17 Suzuki R, Kato T, Miyazaki Y et al. Matrix metalloproteinases and tissue inhitibors of matrix metalloproteinases in sputum from patients with bronchial asthma. J Asthma 2001; 38: 477-484
• 18 Ma X, Cheng Z, Kong H et al. Changes in biophysical and biochemical properties of single bronchial smooth muscle cells from asthmatic subjects. Am J Physiol (Lung Cell Mol Physiol) 2002; 283: L1181-L1189
• 19 Stephens NL, Fust A, Jiang H et al. Isotonic relaxation of controll and sensitized airway smooth muscle. Can J Physiol Pharmacol 2005; 83: 941-951
• 20 Cox G, Thomson NC, Rubin AS et al. Asthma control during the year after bronchial thermoplasty. N Engl J Med 2007; 356: 1327-1337
• 21 Cox G, Miller D, McWilliams A et al. Bronchial thermoplasty for asthma. Am J Respir Crit Care Med 2006; 173: 965-969
• 22 Murphy DM, O'Byrne PM. Recent advances in the pathophysiology of asthma. Chest 2010; 137: 1417-1426
• 23 Koziol-White CJ, Panettieri Jr RA. Airway smooth muscle and immunomodulation in acute exacerbations of airway disease. Immunol Rev 2011; 242: 178-185
• 24 Johnson PR, Roth M, Tamm M et al. Airway smooth muscle cell proliferation is increased in asthma. Am J Physiol (Lung Cell Mol Physiol) 2001; 164: 474-477
• 25 Hollins F, Kaur D, Yang W et al. Human airway smooth muscle promotes human lung mast cell survival proliferation, and constitutive activation: cooperative roles for CADM1, stemm cell factor, and IL-6. J Immunol 2008; 181: 2772-2780
• 26 James AL, Bai TR, Mauad T et al. Airway smooth muscle thickness in asthma is related to severity but not duration of asthma. Eur Respir J 2009; 34: 1040-1045
• 27 Grainge CL, Lauri CK, Ward JA et al. Effect of bronchoconstriction on airway remodeling in asthma. N Engl J Med 2011; 364: 2006-2015
• 28 Tschumperlin DJ, Drazen JM. Mechanical stimuli to airway remodeling. Am J Respir Crit Care Med 2001; 164: 90-S94
• 29 Black JL, Roth M, Lee J et al. Mechanisms of airway remodeling. Am J Respir Crit Care Med 2001; 164: S66
• 30 Yan ZQ, Hansson GK, Skoogh BE et al. Induction of nitric oxide synthase in a model of allergic occupational asthma. Allergy 1995; 50: 760-764
• 31 Williams MC. Maximizing morphologic data from lung biopsies from normal and asthmatic humans. Am J Respir Crit Care Med 1994; 150: 2-5
• 32 Gosens R, Zaagsma J, Meurs H et al. Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Resp Research 2007; 7
• 33 Gosens R, Zaagsma J, Bromhaar MG et al. Acetylcholine: a novel regulator of airway smooth muscle remodelling?. Eur J Pharmacol 2005; 500: 193-201
• 34 Slats AM, Janssen LJ, Schadewijk vA et al. Expression of smooth muscle and extracellular matrix proteins in relation to airway function in asthma. J Allergy Clin Immunol 2008; 121: 1196-1292
• 35 Dekkers BG, Schaafsma D, Nelemans SA et al. Extracellular matrix proteins differentially regulate airway smooth muscle phenotype and function. Am J Physiol Lung Cell Mol Physiol 2007; 292: L1405-L1413
• 36 Gillissen A, Richter A, Oster H et al. Efficacy and safety of once or twice daily inhalation of extrafine HFA beclomethasone dipropionate in patients with mild to moderate asthma. J Physiol Pharmacol 2007; 58: 233-241
• 37 Buhl R, Berdel D, Criée C-P et al. Leitlinie zur Diagnostik und Therapie von Patienten mit Asthma der Deutschen Atemwegsliga und der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V. Pneumologie 2006; 60: 139-183
• 38 GINA Executive and Science Committee (Hrsg). Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. Bethesda, USA: U.S. Department of Health and Human Services; 2010
• 39 Currani SR, Viswanathan RK, Busse WW. What effect does asthma treatment have on airway remodeling? Current perspectives. J Allergy Clin Immunol 2011; 128: 439-448
• 40 Erjefalt JS, Erjefalt I, Sundler F et al. In vivo restitution of airway epithelium. Cell Tissue Res 1995; 281: 305-316
• 41 Dorscheid DR, Wojcik KP, Sun S et al. Apoptosis of airway epithelial cells induced by corticosteroids. Am J Respir Crit Care Med 2001; 164: 1939-1947
• 42 Hoshino M, Takahashi M, Takai Y et al. Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinas-1 expression in asthma. J Allergy Clin Immunol 1999; 104: 356-363
• 43 Mauad T, Bel EH, Sterk PJ. Asthma therapy and airway remodeling. J Allergy Clin Immunol 2011; 120: 997-1009
• 44 Felits BN, Wignarajah D, Reid DW et al. Effects of inhaled fluticasone on angiogenesis and vascular endothelial growth factor in asthma. Thorax 2007; 62: 314-319
• 45 Mendes ES, Pereira A, Danta I et al. Comparative bronchial vasoconstrictive efficacy of inhaled glucocorticosteroids. Eur Respir J 2003; 21: 989-993
• 46 Vlahos R, Lee KS, Guida E et al. Differential inhibition of thrombin- and EGF-stimulated human cultured airway smooth muscle proliferation by glucocorticoids. Pulm Phamacol Therapeutics 2003; 16: 171-180
• 47 De Kluijver J, Schrumpf JA, Evertse CE et al. Bronchial matrix and inflammation respond to inhaled steroids despite ongoing allergen exposure in asthma. Clin Exp Allergy 2005; 35: 1361-1369
• 48 Muz MH, Deveci F, Bulut Y et al. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling und cystenyl leukotriene expression in a mouse asthma model. Exp Mol Med 2006; 38: 109-118
• 49 Henderson Jr WR, Chiang GK, Tien YT et al. Reversal of allergen-induced airway remodeling by CysLT1 receptor blockade. Am J Respir Crit Care Med 2006; 173: 718-728
• 50 Peters SP, Kunselman S, Icitovic N et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 2010; 363: 1715-1726
• 51 O'Connor BJ, Towse LJ, Barnes PJ. Prolonged effect of tiotropium bromide on methacholine-induced bronchoconstriction in asthma. Am J Respir Crit Care Med 1996; 154: 876-880
• 52 Vacca G, Randerath W, Gillissen A. Inhibition of granulocyte migration by tiotropium bromide. Respir Res 2011; 12: 24
• 53 Pera T, Zuidhof A, Valadas J et al. Tiotropium inhibits pulmonary inflammation and remodelling in guinea pig model of COPD. Eur Respir J 2011; 38: 789-796
• 54 Pieper MP, Chaudhary NI, Park JE. Acetylcholine-induced proliferation of fibroblasts and myofibroblasts in vitro is inhibited by tiotropium bromide. Life Sci 2007; 80: 2270-2273
• 55 Bühling F, Lieder N, Kühlmann UC et al. Tiotropium suppresses acetylcholine-induced release of chemotactic mediators in vitro. Respir Med 2007; 101: 2386-2394
• 56 Gosens R, Bos ST, Zaagsma J et al. Protective effects of tiotropium bromide in the progresse of airway smooth muscle remodeling. Am J Respir Crit Care Med 2005; 171: 1096-1102
• 57 Matthiesen S, Bahulayan A, Kempkens S et al. Muscarinic receptors mediate stimulation of human lung fibroblast proliferation. Am J Respir Cell Mol Biol 2006; 35: 621-627
• 58 Haag S, Matthiesen S, Juergens UR et al. Muscarinic receptors mediate stimulation of collagen synthesis in human lung fibroblasts. Eur Respir J 2008; 32: 555-562
• 59 Bos IS, Gosens R, Zuidhof AB et al. Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparision. Eur Respir J 2007; 30: 653-661
• 60 Howarth P, Babu KS, Arshad HS et al. Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax 2005; 60: 1012-1018
• 61 Erin EM, Leaker BR, Nicholson GC et al. The effects of a monoclonal antibody directed against tumor necrosis factor-alpha in asthma. Am J Respir Crit Care Med 2006; 174: 753-762
• 62 Berry MA, Hargadon B, Shelley M et al. Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med 2006; 354: 697-708
• 63 Buhl R, Hanf G, Solér M et al. The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma. Eur Respir J 2002; 20: 1088-1094
• 64 Fahy JV, Fleming E, Wong HH et al. The effect of an anti-IgE monoclonal antibody on the early- and late phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med 1997; 155: 1828-1834
• 65 Lanier BQ, Corren J, Lumry W et al. Omalizumab is effective in the long-term control of severe all asthma. Ann Allergy Asthma Immunol 2003; 91: 154-159
• 66 Solér M, Matz J, Townley R et al. The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. Eur Respir J 2001; 18: 254-261
• 67 Rabe KF, Calhoun WJ, Smith N et al. Can anti-IgE therapy prevent airway remodeling in allergic asthma?. Allergy 2011; 66: 1142-1151
• 68 Kang JY, Kim JW, Kim SJ et al. Inhibitory effects of anti-immunoglobulin E antibodies on airway remodeling in a murin model of chronic asthma. J Asthma 2010; 47: 374-380
• 69 Krause S, Behrends J, Borowski A et al. Blockade of interleukin-13-mediated cell activation by a novel inhibitory antibody to human IL-13 receptor alpha1. Mol Immunol 2006; 43: 1799-1807
• 70 Myrtek D, Knoll M, Matthiesen T et al. Expression of interleukin-13 receptor alpha 1-subunit ond peripheral blood eosinophils is regulated by cytokines. Immunology 2004; 112: 597-604
• 71 Julius P, Hochheim D, Boser K et al. Interleukin-5 receptors on human lung eosinophiles after segmental allergen challenge. Clin Exp Allergy 2004; 34: 1064-1070
• 72 Bundschuh DS, Eltze M, Barsig J et al. In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor. J Pharmacol Exp Ther 2001; 297: 280-289
• 73 Wegmann M, Göggel R, Sel S et al. Effects of a low-molecular-weight CCR-3 antagonist on chronic experimental asthma. Am J Respir Crit Care Med 2007; 36: 61-67
• 74 Hoshino M, Fujita Y, Saji J et al. Effect of suplatast tosilate on goblet cell metaplasie in patients with asthma. Allergy 2005; 60: 1394-1400
• 75 Karras JG, Crosby JR, Guha M et al. Anti-inflammatory activity of inhaled IL-4 receptor-alpha antisense oligonucleotide in mice. Am J Respir Crit Care Med 2007; 36: 276-285
• 76 Tomkinson A, Duez C, Cieslewicz G et al. A murine IL-4 receptor antagonist that inhibits IL-4- and IL-13-induced responses prevents antigen-induced airway eosinophilia and airway hyperresponsiveness. J Immunol 2001; 166: 5792-5800
• 77 Shardonofsky F, Venzor J, Barrios R et al. Therapeutic efficacy of an anti-IL-5 monocolonal antibody delivered into the respiratory tract in a murine model of asthma. J Allergy Clin Immunol 1999; 104: 215-221
• 78 Leckie MJ. Anti-IL-5 monoclonal antibodies: preclinical and clinical evidence in asthma models. Am J Respir Med 2003; 3: 245-259
• 79 Hashimoto T, Akiyama K, Kawaguchi H et al. Correlation of allergen-induced IL-5 and IL-13 production by peripheral blood T cells of asthma patients. Int Arch Allergy Appl Immunol 2004; 134: 7-11
• 80 Grunig G, Warnock M, Wakil AE et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998; 282: 2261-2263
• 81 Yang G, Vok A, Petley T et al. Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling. Cytokine 2004; 28: 224-232
• 82 Fattouh R, Midence NG, Arias K et al. Transforming growth factor-beta regulates house dust mite-induced allergic airway inflammation but not airway remodeling. Am J Respir Crit Care Med 2008; 177: 593-603
• 83 Oh SW, Pae CL, Lee DK et al. Tryptase inhibition blocks airway inflammation in a mouse asthma model. J Immunol 2002; 168: 1992-2000
• 84 Fanucchi MV, Schelegle ES, Baker GL et al. Immunostimulatory oligonucleotides attenuate airways remodelling in allergic monkeys. Am J Respir Crit Care Med 2004; 170: 1153-1157
• 85 Camateros P, Tamaoka M, Hassan M et al. Chronic asthma-induced airway remodeling is prevented by Toll-like receptor-7/8 ligand S28463. Am J Respir Crit Care Med 2007; 175: 1241-1249
• 86 Kumar RK, Herbert C, Thomas PS et al. Inhitibtion of inflammatory and remodeling by roflumilast and dexamethasone in murine chronic asthma. J Pharmacol Exp Ther 2003; 307: 349-355
• 87 Burgess JK, Oliver BG, Poniris MH et al. A phosphodiesterase 4 inhibitor inhibits matrix protein deposition in airways in vitro. J Allergy Clin Immunol 2006; 118: 649-657
• 88 Cortijo J, Iranzo A, Milara X et al. Roflumilast, a phosphodiesterase 4 inhibitor, alleviates bleomycin-induced lung injury. Br J Pharmacol 2009; 156: 534-544
• 89 Camoretti-Mercado B. Targeting the airway smooth muscle for asthma treatment. Transl Res 2009; 154: 165-174
• 90 Schaafsma D, McNeill KD, Mutawe MM et al. Simvastatin inhibits TGFß1-induced fibronectin in human airway fibroblasts. Resp Research 2011; 12: 113 (e-pub)
• 91 Chiba Y, Sato S, Misawa M. Upregulation of geranylgeranyltransferase I in bronchial smooth muscle of mouse experimental asthma: its inhibition by lovastatin. J Smooth Muscle Res 2010; 46: 57-64
• 92 Maneechotesuwan K, Ekjiratrakul W, Kasetsinsombat K et al. Statins enhance the anti-inflammatory effects of inhaled corticosteroids in asthma patients through increased induction of indoleamine 2, 3-dioxygenase. J Allergy Clin Immunol 2010; 126: 754-762
• 93 Zeki AA, Bratt JM, Rabowsky M et al. Simvastatin inhibits goblet cell hyperplasia and lung arginase in a mouse model of allergic asthma: a novel treatment for airway remodeling?. Transl Res 2010; 156: 335-349
• 94 Wahidi MM, Kraft M. Bronchial thermoplasty for severe asthma. Am J Respir Crit Care Med 2011; 185: 709-714